| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 3,106,157 | |||
| Prepaid expenses and other current assets | 188,583 | |||
| Total current assets | 3,294,740 | |||
| Right-of-use asset | 89,423 | |||
| Intangible assets, net | 904,885 | |||
| Security deposit | 8,582 | |||
| Total assets | 4,297,630 | |||
| Accounts payable and accrued expenses | 2,264,425 | |||
| Current portion of operating lease liability | 44,829 | |||
| Total current liabilities | 2,309,254 | |||
| Operating lease liability, net of current portion | 46,344 | |||
| Deferred revenue | 1,438,013 | |||
| Total liabilities | 3,793,611 | |||
| Common stock, 0.0001 par value, 500 million and 40 million shares authorized at september 30, 2025 and december 31, 2024, respectively 28,022,826 and 26,845,690 shares issued at september 30, 2025 and december 31, 2024, respectively | 2,802 | |||
| Additional paid-in capital | 23,223,079 | |||
| Subscription receivable | 52,699 | |||
| Accumulated deficit | -22,669,163 | |||
| Total stockholders equity (deficit) | 504,019 | |||
| Total liabilities and stockholders equity (deficit) | 4,297,630 | |||
Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc. (TTRX)